In the largest study of its kind to date, insulin pumps lead to better blood sugar control in individuals with type 2 diabetes who have previously failed to respond to the typical standard of care. According to the new international study, individuals’ blood sugar levels were controlled more readily with insulin pumps than through the traditional course of several daily injections.
The international study, the largest to date to look into how safely and effectively pumps treat type 2 diabetes, was published in The Lancet.
Type 2 diabetes is routinely controlled through diet and medication. However, those with advanced disease typically require insulin therapy to help control their blood sugar levels. Nearly a third of these patients experience difficulty obtaining the right blood sugar level when using insulin injections several times per day.
Professor Yves Reznik from the University of Caen Côte de Nacre Regional Hospital Center in France and lead study author, said in a statement, “Pumps enhance effective insulin absorption and increase insulin sensitivity thanks to the continuous daily subcutaneous insulin delivery. Our findings open up a valuable new treatment option for those individuals failing on current injection regimens and may also provide improved convenience, reducing the burden of dose tracking and scheduling, and decreasing insulin injection omissions.”
According to WebMD, type 2 diabetes is the most common form of diabetes among Americans, affecting between 90 and 95 percent of the 26 million Americans who have diabetes.